Safety of SGLT2 inhibitors in very elderly diabetic type 2 patients in real life
Fuente:
Redalyc
Saved in:
| Main Author: | Ramón Baeza-Trinidad |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Hospital San Pedro
2023
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
The Association of SGLT-2 inhibitors (Empagliflozin) with the development of hypernatremic dehydration: a case report
by: Diana Alegre-González
Published: (2025)
by: Diana Alegre-González
Published: (2025)
EVALUATION OF THE EFFICACY OF SGLT2 INHIBITOR THERAPY IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION
by: Cotoneț, Tatiana, et al.
Published: (2025)
by: Cotoneț, Tatiana, et al.
Published: (2025)
Sodium-Glucose Co-Transporter Type 2 Inhibitors and Heart Failure: A Review of the State of the Art
by: Yilmar Alexader Meza-González
Published: (2023)
by: Yilmar Alexader Meza-González
Published: (2023)
Visión integral de la farmacología de los inhibidores de los co-transportadores de sodio/glucosa: pasado, presente y futuro
by: Alex Patricio Morales Carrasco
Published: (2020)
by: Alex Patricio Morales Carrasco
Published: (2020)
SGLT2 Inhibitors: Pharmacology and Expanding Role Beyond Diabetes
by: Shivcharan Kamble*, Rashee Shahu, Sunita Kode, Tejaswini Gaikwad, Pooja Rasal
Published: (2026)
by: Shivcharan Kamble*, Rashee Shahu, Sunita Kode, Tejaswini Gaikwad, Pooja Rasal
Published: (2026)
IDENTIFICACIÓN Y EVALUACIÓN DE TRANSPORTADORES DE GLUCOSA SGLT1 Y GLUT2 Y LA INCRETINA GLP-1 EN INTESTINO DELGADO DE CUYES (Cavia porcellus)
by: Juan Anglas P.
Published: (2012)
by: Juan Anglas P.
Published: (2012)
Biología molecular de los transportadores de glucosa: clasificación, estructura y distribución
by: Lisney Valdelamar
Published: (2007)
by: Lisney Valdelamar
Published: (2007)
Dapagliflozin – derribando barreras en el tratamiento actual de la diabetes mellitus
by: Nadia Shiguango Shiguango
Published: (2020)
by: Nadia Shiguango Shiguango
Published: (2020)
Insuficiencia cardíaca y diabetes Nuevos tratamientos para la diabetes
by: Cecilia Perel
Published: (2018)
by: Cecilia Perel
Published: (2018)
Características diferenciales del empagliflozin en el tratamiento de la diabetes mellitus
by: Vicente David Aguilera Moreira
Published: (2021)
by: Vicente David Aguilera Moreira
Published: (2021)
Renal Glycosuria Induced by Acute Thioacetamide Administration to Rats
by: Freddy Gonzalez-Mujica
Published: (2007)
by: Freddy Gonzalez-Mujica
Published: (2007)
IDENTIFICACIÓN INMUNOHISTOQUÍMICA DE TRANSPORTADORES DE GLUCOSA INTESTINAL Y ABSORCIÓN DE GLUCOSA DURANTE EL DESARROLLO Y MADURACIÓN DEL INTESTINO DELGADO DE CRÍAS DE ALPACAS
by: José Rodríguez G.
Published: (2012)
by: José Rodríguez G.
Published: (2012)
CHRONIC HEART FAILURE: MODERN DIAGNOSTIC AND THERAPEUTIC APPROACHES
by: Salohiddinova Hojaroy, et al.
Published: (2025)
by: Salohiddinova Hojaroy, et al.
Published: (2025)
Особенности влияния новых классов сахароснижающих препаратов на сердечно-сосудистые исходы у пациентов с сахарным диабетом 2 типа
by: Музафарова Ш.Ш., et al.
Published: (2026)
by: Музафарова Ш.Ш., et al.
Published: (2026)
Incidence and risk factors of major toxicity associated to first-line antituberculosis drugs for latent and active tuberculosis during a period of 10 years
by: Ana Tavares e Castro
Published: (2015)
by: Ana Tavares e Castro
Published: (2015)
Pruebas modificadas de degranulación de basófilos y factor de inhibición de migración de leucocitos en alergia a fármacos. Estudio de 2009 a 2014
by: María de Lourdes Irigoyen-Coria
Published: (2016)
by: María de Lourdes Irigoyen-Coria
Published: (2016)
Adverse drug reactions in internal medicine units at a university hospital: A descriptive pilot study
by: LUIS CARLOS LÓPEZ
Published: (2010)
by: LUIS CARLOS LÓPEZ
Published: (2010)
The PharmWatch programme: challenges to engaging the community pharmacists in Jamaica
by: Maxine GOSSELL-WILLIAMS
Published: (2008)
by: Maxine GOSSELL-WILLIAMS
Published: (2008)
Pulmonary nocardiosis treated with tedizolid
by: Víctor Giménez-Arufe
Published: (2019)
by: Víctor Giménez-Arufe
Published: (2019)
Characterization of adverse events during the treatment with heberprot-P in four cuban provinces.
by: Alina R. Alvarez Crespol
Published: (2015)
by: Alina R. Alvarez Crespol
Published: (2015)
Clinical pharmacology of cannabidiol in refractory epilepsy
by: Paula Schaiquevich
Published: (2020)
by: Paula Schaiquevich
Published: (2020)
PREVENTIVE STRATEGIES OF ADVERSE EVENTS WITH POTENTIALLY DANGEROUS MEDICATIONS
by: Flavia Giron Camerini
Published: (2013)
by: Flavia Giron Camerini
Published: (2013)
Patologías dermatológicas de origen nutricional en los pequeños animales: una revisión
by: María S. Gonzalez-Dominguez
Published: (2016)
by: María S. Gonzalez-Dominguez
Published: (2016)
Interstitial Lung Disease Associated with Chronic Nitrofurantoin Use
by: Erick Jafet González Roblero, et al.
Published: (2025)
by: Erick Jafet González Roblero, et al.
Published: (2025)
Relationship between anticholinergic load and selfperceived health in a population aged 44 years or older
by: Eliz Cassieli Pereira Pinto
Published: (2023)
by: Eliz Cassieli Pereira Pinto
Published: (2023)
Comparison of effects of m-TOR inhibitors and calcineurin inhibitor on SUPAR and ox-LDL levels in renal transplant recipients
by: Banu Yılmaz
Published: (2022)
by: Banu Yılmaz
Published: (2022)
Rethinking pharmacovigilance: Building inclusive drug safety systems for marginalized populations
by: Jain, Ashish, et al.
Published: (2025)
by: Jain, Ashish, et al.
Published: (2025)
Cardiotoxicity associated with trastuzumab in normal clinical practice
by: C. Vicente
Published: (2009)
by: C. Vicente
Published: (2009)
What are the comparative outcomes of DPP-4 inhibitors versus SGLT-2 inhibitors in treating type 2 diabetes across various countries in the UK?
by: Tripdatabase
Published: (2025)
by: Tripdatabase
Published: (2025)
Echoes of early-life stress on suicidal behavior in individuals with substance use disorder
by: Elton Brás Camargo Júnior
Published: (2023)
by: Elton Brás Camargo Júnior
Published: (2023)
Negative results related to drugs required in hospitalisation
by: A. Santamaría-Pablos
Published: (2009)
by: A. Santamaría-Pablos
Published: (2009)
Hypertensive elderly people: assessing the quality of life
by: Larissa Cristina Rodrigues Alencar
Published: (2019)
by: Larissa Cristina Rodrigues Alencar
Published: (2019)
Acquired hemophilia in an elderly person
by: SANDRA MILENA CASTELBLANCO-TORO
Published: (2019)
by: SANDRA MILENA CASTELBLANCO-TORO
Published: (2019)
Dementia post-radiotherapy: improvement with acetylcholinesterase inhibitor. A case report
by: Antonio Eduardo Damin
Published: (2009)
by: Antonio Eduardo Damin
Published: (2009)
Renin inhibitors as antihypertensive agents
by: Zafar H. Israili
Published: (2008)
by: Zafar H. Israili
Published: (2008)
Characteristics of a long-stay institution for the elderly
by: Nadjara Marciele do Nascimento Silva
Published: (2017)
by: Nadjara Marciele do Nascimento Silva
Published: (2017)
Cognitive performance of long-term institutionalized elderly patients with schizophrenia. A case control study
by: Alexandre Paim Diaz
Published: (2011)
by: Alexandre Paim Diaz
Published: (2011)
Perception of elderly on alzheimer
by: Ronaldo Bezerra de Queiroz
Published: (2016)
by: Ronaldo Bezerra de Queiroz
Published: (2016)
Pharmacokinetics and pharmacodynamics of the new oral anticoagulants
by: Juan Pablo Ordovás Baines
Published: (2009)
by: Juan Pablo Ordovás Baines
Published: (2009)
Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study
by: Eyyup Cavdar
Published: (2022)
by: Eyyup Cavdar
Published: (2022)
Similar Items
-
The Association of SGLT-2 inhibitors (Empagliflozin) with the development of hypernatremic dehydration: a case report
by: Diana Alegre-González
Published: (2025) -
EVALUATION OF THE EFFICACY OF SGLT2 INHIBITOR THERAPY IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION
by: Cotoneț, Tatiana, et al.
Published: (2025) -
Sodium-Glucose Co-Transporter Type 2 Inhibitors and Heart Failure: A Review of the State of the Art
by: Yilmar Alexader Meza-González
Published: (2023) -
Visión integral de la farmacología de los inhibidores de los co-transportadores de sodio/glucosa: pasado, presente y futuro
by: Alex Patricio Morales Carrasco
Published: (2020) -
SGLT2 Inhibitors: Pharmacology and Expanding Role Beyond Diabetes
by: Shivcharan Kamble*, Rashee Shahu, Sunita Kode, Tejaswini Gaikwad, Pooja Rasal
Published: (2026)